Elevated levels of serum antibodies against Saccharomyces cerevisiae mannan in patients with systemic lupus erythematosus

Lupus

Volumn 18, Issue 12, 2009, Pages 1087-1090

  Dai, H ^a,b   Li, Z ^c   Zhang, Y ^a   Lv, P ^a   Gao, X M ^a,b  

^a PEKING UNIVERSITY HEALTH SCIENCE CENTER   (China)

^b BEIJING HOSPITAL   (China)

^c PEKING UNIVERSITY PEOPLE S HOSPITAL   (China)

Author keywords

1,3 mannan; Autoantibody; Autoimmune diseases; SLE

Indexed keywords

FUNGUS ANTIBODY; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; SACCHAROMYCES CEREVISIAE MANNAN ANITBODY; UNCLASSIFIED DRUG;

ADULT; ANTIBODY BLOOD LEVEL; ANTIBODY DETECTION; ARTICLE; BLOOD SAMPLING; CLINICAL ARTICLE; CONTROLLED STUDY; CROSS REACTION; DISEASE ACTIVITY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; MALE; PATIENT ASSESSMENT; PRIORITY JOURNAL; REMISSION; SACCHAROMYCES CEREVISIAE; SYSTEMIC LUPUS ERYTHEMATOSUS;

ADOLESCENT; ADULT; ANTIBODIES, FUNGAL; BIOLOGICAL MARKERS; CROHN DISEASE; FEMALE; HUMANS; IMMUNOGLOBULIN G; LUPUS ERYTHEMATOSUS, SYSTEMIC; MALE; MANNANS; MIDDLE AGED; ROC CURVE; SACCHAROMYCES CEREVISIAE; YOUNG ADULT;

EID: 70349514874     PISSN: 09612033     EISSN: None     Source Type: Journal    
DOI: 10.1177/0961203309105131     Document Type: Article

References (15)

1. Damoiseaux, JG, Bouten, B, Linders, AM, et al. Diagnostic value of anti-Saccharomyces cerevisiae and antineutrophil cytoplasmic antibodies for inflammatory bowel disease: High prevalence in patients with celiac disease. J Clin Immunol 2002; 22: 281-288.
2. Dotan, N, Altstock, RT, Schwarz,M, Dukler, A. Anti-glycan antibodies as biomarkers for diagnosis and prognosis. Lupus 2006; 15: 442-450.
3. Dotan, I, Fishman, S, Dgani, Y, et al. Antibodies against laminaribioside and chitobioside are novel serologic markers in Crohn's disease. Gastroenterology 2006; 131: 366-378.
4. Israeli, E, Grotto, I, Gilburd, B, et al. Anti-Saccharomyces cerevisiae and antineutrophil cytoplasmic antibodies as predictors of inflammatory bowel disease. Gut 2005; 54: 1232-1236.
5. Krause, I, Monselise, Y, Milo, G, Weinberger, A. Anti-Saccharomyces cerevisiae antibodies-a novel serologic marker for Behcet's disease. Clin Exp Rheumatol 2002; 20: S21-S24.
6. Muratori, P, Muratori, L, Guidi, M, et al. Anti-Saccharomyces cerevisiae antibodies (ASCA) and autoimmune liver diseases. Clin Exp Immunol 2003; 132: 473-476.
7. Hoffman, IE, Demetter, P, Peeters, M, et al. Anti-Saccharomyces cerevisiae IgA antibodies are raised in ankylosing spondylitis and undifferentiated spondyloarthropathy. Ann Rheum Dis 2003; 62: 455-459.
8. Riente, L, Chimenti, D, Pratesi, F, et al. Antibodies to tissue transglutaminase and Saccharomyces cerevisiae in ankylosing spondylitis and psoriatic arthritis. J Rheumatol 2004; 31: 920-924.
9. Tan, EM, Cohen, AS, Fries, JF, et al. The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1982; 25: 1271-1277.
10. Hahn, BH, McMahon, M. Atherosclerosis and systemic lupus erythematosus: the role of altered lipids and of autoantibodies. Lupus 2008; 17: 368-370.
11. Veys, EM, Mielants, H. Enteropathic arthropathies. In: Klippel, J, Dieppe, PA, (ed), Rheumatology. London: Mosby International; 1998. p. 1-8.
12. Bourne, JT, Kumar, P, Huskisson, EC, Mageed, R, Unsworth, DJ, Wojtulewski, JA. Arthritis and coeliac disease. Ann Rheum Dis 1985; 44: 592-598.
13. Krause, I, Blank, M, Cervera, R, et al. Cross-reactive epitopes on beta2-glycoprotein-I and Saccharomyces cerevisiae in patients with the antiphospholipid syndrome. Ann N Y Acad Sci 2007; 1108: 481-488.
14. Saiki, M, Sakai, K, Saiki, S, Kitagawa, Y, Nakanishi, M, Hirose, G. Induction of humoral responses specific for paraneoplastic cerebellar degeneration-associated antigen by whole recombinant yeast immunization. J Autoimmun 2005; 24: 203-208.
15. Klein, J, Horejsi, V. Defense reactions mediated by macrophages. In: Klein, J, (ed), Immunology. 2nd ed. Oxford: Blackwell Science; 1997. p. 442-447.